Drugs / S CKD602
last change May 2006 re-read 3 minutes ago

S CKD602

Developed for
cancer
Investigated by
ALZA · University of Pittsburgh

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00177281 Sep 2003 → May 2006 cancer University of Pittsburgh Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as S-CKD602 “the study drug S-CKD602 is broken down in a subject's body” NCT00177281 ↗
1

NCT00177281 ↗